封面
市场调查报告书
商品编码
1618197

医疗保健 3D 列印市场机会、成长动力、产业趋势分析和 2024 年至 2032 年预测

Healthcare 3D Printing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年,全球医疗保健3D 列印市场价值为29 亿美元,预计2024 年至2032 年复合年增长率为18.6%。 。 3D列印技术在临床环境中的广泛使用是促进市场成长的主要因素。这种创新方法可以创建高度客製化的医疗设备,包括专门为满足个别患者的解剖学需求而量身定制的植入物、义肢和手术器械。这种客製化可以显着提高治疗效果。

此外,3D 列印也被用来产生准确的解剖模型,以帮助制定手术计划,减少出错的可能性并提高手术过程中的精确度。该市场按产品类型细分,包括基于喷墨、基于注射器、基于雷射和磁悬浮技术。基于注射器的细分市场到 2023 年将产生约 12 亿美元的收入。基于注射器的系统的精度和控制使其非常适合医疗保健环境,特别是在研究和再生医学领域。

它们在管理水凝胶和生物墨水等各种材料方面的多功能性,进一步巩固了它们在组织工程和药物测试中的作用。在审查应用时,医疗保健 3D 列印市场涵盖医疗、牙科和生物感测器领域。预计医疗应用领域在预测期内将产生最高收入,达到 68 亿美元。此细分市场涵盖骨科和心血管植入物等重要领域,使其成为医疗保健提供者和研究人员的焦点。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 29亿美元
预测值 138 亿美元
复合年增长率 18.6%

医疗 3D 列印技术的进步可以生产个人化医疗设备和植入物,满足患者独特的解剖学需求,显着提高治疗效果和整体患者护理。北美在医疗保健3D 列印市场中占有相当大的份额,到2023 年将产生11 亿美元的收入。方案的采用已成为人们关注的焦点。在政府大量资金的支持下,生物列印和 3D 列印医疗设备领域的持续创新由北美领先的医疗机构和大学带头。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 技术进步
      • 扩展临床应用
      • 对客製化植入物的需求不断增长
      • 增加製造商和机构的研发投入
    • 产业陷阱与挑战
      • 缺乏熟练的专业人员
      • 3D列印的高价格
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 报销场景
  • 2023 年按产品定价分析
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势
  • 差距分析
  • 价值链分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品分类,2021 - 2032 年

  • 主要趋势
  • 基于注射器
  • 基于喷墨
  • 基于雷射
  • 磁浮

第 6 章:市场估计与预测:按技术分类,2021 - 2032 年

  • 主要趋势
  • 熔融沈积建模 (FDM)
  • 选择性雷射烧结(SLS)
  • 立体光刻
  • 其他技术

第 7 章:市场估计与预测:按应用分类,2021 - 2032

  • 主要趋势
  • 医疗的
    • 药品
    • 义肢和植入物
    • 组织和器官生成
  • 牙科
  • 生物感测器

第 8 章:市场估计与预测:按材料划分,2021 - 2032 年

  • 主要趋势
  • 聚合物
  • 金属和合金
  • 生物材料
  • 其他材料

第 9 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 10 章:公司简介

  • 3D Biotek
  • 3D Systems
  • Aprecia Pharmaceuticals
  • Aspect Biosystems
  • Cyfuse Biomedical
  • Dassault Systemes
  • Envision TEC
  • Materialise
  • Metamorph 3D print services
  • Nano3D Biosciences
  • Oceanz
  • REGENHU
  • Renishaw
  • Stratasys
  • Xometry
简介目录
Product Code: 1997

The Global Healthcare 3D Printing Market was valued at USD 2.9 billion in 2023 and is projected to grow at a CAGR of 18.6% from 2024 to 2032. This growth is largely driven by increased research and development investments from manufacturers and institutions, along with a broadening array of clinical applications. The expanding use of 3D printing technology in clinical settings is a major factor contributing to market growth. This innovative approach allows the creation of highly customized medical devices, including implants, prosthetics, and surgical instruments tailored specifically to meet the anatomical needs of individual patients. Such customization significantly enhances treatment outcomes.

Additionally, 3D printing is being utilized to produce accurate anatomical models that aid in surgical planning, reducing the likelihood of errors and improving precision during procedures. The market is segmented by product types, including inkjet-based, syringe-based, laser-based, and magnetic levitation technologies. The syringe-based segment generated around USD 1.2 billion in revenue in 2023. These systems are particularly advantageous in bioprinting applications, where tissues and organs are crafted using bio-inks that contain living cells. The precision and control of syringe-based systems make them highly suitable for healthcare environments, especially in research and regenerative medicine.

Their versatility in managing various materials, such as hydrogels and bio-inks, further cements their role in tissue engineering and drug testing. When examining applications, the healthcare 3D printing market encompasses the medical, dental, and biosensor sectors. The medical applications segment is projected to yield the highest revenue of USD 6.8 billion during the forecast period. This segment covers essential areas such as orthopedics and cardiovascular implants, making it a focal point for healthcare providers and researchers.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$2.9 Billion
Forecast Value$13.8 Billion
CAGR18.6%

The advancements in medical 3D printing technology allow the production of personalized medical devices and implants that cater to the unique anatomical needs of patients, significantly enhancing treatment efficacy and overall patient care. North America holds a substantial share of the healthcare 3D printing market, generating USD 1.1 billion in revenue in 2023. This region is expected to experience a CAGR of 18% from 2024 to 2032. The embrace of advanced medical devices and personalized treatment options has been pivotal in propelling the growth of 3D printing within healthcare. The ongoing innovations in bioprinting and 3D-printed medical devices, backed by significant government funding, are being spearheaded by leading healthcare institutions and universities in North America.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancements
      • 3.2.1.2 Extended clinical applications
      • 3.2.1.3 Rising demand for custom implants
      • 3.2.1.4 Increasing R&D investments from manufacturers and institutions
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Lack of skilled professionals
      • 3.2.2.2 High price associated with 3D printing
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Pricing analysis, by product, 2023
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends
  • 3.11 Gap analysis
  • 3.12 Value-chain analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Syringe based
  • 5.3 Inkjet based
  • 5.4 Laser based
  • 5.5 Magnetic levitation

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Fused deposition modelling (FDM)
  • 6.3 Selective laser sintering (SLS)
  • 6.4 Stereolithography
  • 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Medical
    • 7.2.1 Pharmaceuticals
    • 7.2.2 Prosthetics and implants
    • 7.2.3 Tissue and organ generation
  • 7.3 Dental
  • 7.4 Biosensors

Chapter 8 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Polymers
  • 8.3 Metals and alloys
  • 8.4 Biological materials
  • 8.5 Other materials

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 3D Biotek
  • 10.2 3D Systems
  • 10.3 Aprecia Pharmaceuticals
  • 10.4 Aspect Biosystems
  • 10.5 Cyfuse Biomedical
  • 10.6 Dassault Systemes
  • 10.7 Envision TEC
  • 10.8 Materialise
  • 10.9 Metamorph 3D print services
  • 10.10 Nano3D Biosciences
  • 10.11 Oceanz
  • 10.12 REGENHU
  • 10.13 Renishaw
  • 10.14 Stratasys
  • 10.15 Xometry